EP 1480655 A2 20041201 - DNA DEMETHYLASE ANTISENSE AND CHEMOTHERAPY COMBINATION
Title (en)
DNA DEMETHYLASE ANTISENSE AND CHEMOTHERAPY COMBINATION
Title (de)
KOMBINATION VON CHEMOTHERAPIE UND ANTISENSE GEGEN DNA DEMETHYLASE
Title (fr)
COMBINAISON CHIMIOTHTHERAPIE ET ANTISENS DE LA DNA DEMETHYLASE
Publication
Application
Priority
- FR 0300705 W 20030305
- FR 0202879 A 20020307
Abstract (en)
[origin: WO03074060A2] The invention concerns a combination product comprising an antisense oligonucleotide of the gene encoding MBD2-demethylase and at least an agent used in antitumour chemotherapy, in particular bleomycin, for simultaneous, separate or prolonged use for treating proliferative and inflammatory diseases, in particular for cancer treatment.
IPC 1-7
A61K 31/7088; C12N 15/11; A61K 31/04; A61K 38/14; A61P 35/00; A61P 29/00; A61K 31/713; A61K 45/06
IPC 8 full level
A61K 31/7088 (2006.01); A61K 38/14 (2006.01); A61P 29/00 (2006.01); A61P 35/00 (2006.01)
CPC (source: EP US)
A61K 31/7088 (2013.01 - EP US); A61K 38/14 (2013.01 - EP US); A61P 29/00 (2017.12 - EP); A61P 35/00 (2017.12 - EP)
C-Set (source: EP US)
Citation (search report)
See references of WO 03074060A2
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 03074060 A2 20030912; WO 03074060 A3 20040408; WO 03074060 A8 20040610; AU 2003233360 A1 20030916; AU 2003233360 A8 20030916; CA 2478124 A1 20030912; EP 1480655 A2 20041201; FR 2836831 A1 20030912; FR 2836831 B1 20040625; US 2006009403 A1 20060112
DOCDB simple family (application)
FR 0300705 W 20030305; AU 2003233360 A 20030305; CA 2478124 A 20030305; EP 03727568 A 20030305; FR 0202879 A 20020307; US 50676604 A 20041112